Complete Clinical Response to Neoadjuvant Chemotherapy in a 54-year-old Male with Askin Tumor

Abstract

Askin tumor is a tumor of the thoracopulmonary region that most commonly affects children and adolescents. These rare tumors are a form of primitive neuroectodermal tumor and typically carry a poor prognosis. Treatment is multimodal and consists of a combination of neoadjuvant chemotherapy, radical resection, and adjuvant chemo- and radiotherapy or all of the above. Surgery is advocated in most cases. We report a case of Askin tumor in a 54-year-old male who showed rapid and complete response to neoadjuvant chemotherapy. This allowed potentially radical surgery to be avoided. At one-year follow-up he remains disease-free.

Neoadjuvant therapy - chest wall - sarcoma

References

• 1 Veronesi G, Spaggiari L, De Pas T et al. Preoperative chemotherapy is essential for conservative surgery of Askin tumors.  J Thorac Cardiovasc Surg. 2003;  125 (2) 428-429
• 2 Baldini E H, Demetri G D, Fletcher C D et al. Adults with Ewing's sarcoma/primitive neuroectodermal tumor: adverse effect of older age and primary extraosseous disease on outcome.  Ann Surg. 1999;  230 (1) 79-86
• 3 Oberlin O, Deley M C, Bui B N et al. Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study).  Br J Cancer. 2001;  85 (11) 1646-1654
• 4 Grier H E, Krailo M D, Tarbell N J et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.  N Engl J Med. 2003;  348 (8) 694-701
• 5 Shamberger R C, LaQuaglia M P, Gebhardt M C et al. Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy.  Ann Surg. 2003;  238 (4) 563-568